179 related articles for article (PubMed ID: 36626617)
1. Evaluating the risk-benefit ratio of immunotherapy according to liver-functional reserve in advanced HCC: the dark side of the moon.
Cabibbo G; Celsa C; Alimenti E; Iavarone M
Hepatology; 2023 Apr; 77(4):1074-1077. PubMed ID: 36626617
[No Abstract] [Full Text] [Related]
2. Immunotherapy for hepatocellular carcinoma.
Li S; Yang F; Ren X
Drug Discov Ther; 2015 Oct; 9(5):363-71. PubMed ID: 26632545
[TBL] [Abstract][Full Text] [Related]
3. Anti-PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection-Related Advanced Hepatocellular Carcinoma: A Literature Review.
Li B; Yan C; Zhu J; Chen X; Fu Q; Zhang H; Tong Z; Liu L; Zheng Y; Zhao P; Jiang W; Fang W
Front Immunol; 2020; 11():1037. PubMed ID: 32547550
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of hepatocellular carcinoma.
Butterfield LH; Ribas A
Expert Opin Biol Ther; 2002 Feb; 2(2):123-33. PubMed ID: 11849113
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of HCC.
Greten TF; Manns MP; Korangy F
Rev Recent Clin Trials; 2008 Jan; 3(1):31-9. PubMed ID: 18474013
[TBL] [Abstract][Full Text] [Related]
6. [Clinical advances in targeted therapy and immunotherapy for hepatocellular carcinoma].
Zhang DZ; Niu JQ
Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):834-837. PubMed ID: 31941237
[TBL] [Abstract][Full Text] [Related]
7. Immunological landscape and immunotherapy of hepatocellular carcinoma.
Prieto J; Melero I; Sangro B
Nat Rev Gastroenterol Hepatol; 2015 Dec; 12(12):681-700. PubMed ID: 26484443
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects.
Liu Z; Liu X; Liang J; Liu Y; Hou X; Zhang M; Li Y; Jiang X
Front Immunol; 2021; 12():765101. PubMed ID: 34675942
[TBL] [Abstract][Full Text] [Related]
9. Systemic therapy for advanced hepatocellular carcinoma: past, present, and future.
Giglia JL; Antonia SJ; Berk LB; Bruno S; Dessureault S; Finkelstein SE
Cancer Control; 2010 Apr; 17(2):120-9. PubMed ID: 20404795
[TBL] [Abstract][Full Text] [Related]
10. Combinatorial immunotherapy strategies for hepatocellular carcinoma.
Tagliamonte M; Petrizzo A; Tornesello ML; Ciliberto G; Buonaguro FM; Buonaguro L
Curr Opin Immunol; 2016 Apr; 39():103-13. PubMed ID: 26851637
[TBL] [Abstract][Full Text] [Related]
11. [Status Quo and Development of Immunotherapy for Hepatocellular Carcinoma].
Wang T; Wang WT
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):692-698. PubMed ID: 37248607
[TBL] [Abstract][Full Text] [Related]
12. Gene- and immunotherapy for hepatocellular carcinoma.
Palmer DH; Hussain SA; Johnson PJ
Expert Opin Biol Ther; 2005 Apr; 5(4):507-23. PubMed ID: 15934829
[TBL] [Abstract][Full Text] [Related]
13. Therapeutics for advanced hepatocellular carcinoma: Recent advances, current dilemma, and future directions.
Zhu J; Yin T; Xu Y; Lu XJ
J Cell Physiol; 2019 Aug; 234(8):12122-12132. PubMed ID: 30644100
[TBL] [Abstract][Full Text] [Related]
14. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
Xing R; Gao J; Cui Q; Wang Q
Front Immunol; 2021; 12():783236. PubMed ID: 34899747
[TBL] [Abstract][Full Text] [Related]
15. Safety of Combined Yttrium-90 Radioembolization and Immune Checkpoint Inhibitor Immunotherapy for Hepatocellular Carcinoma.
Zhan C; Ruohoniemi D; Shanbhogue KP; Wei J; Welling TH; Gu P; Park JS; Dagher NN; Taslakian B; Hickey RM
J Vasc Interv Radiol; 2020 Jan; 31(1):25-34. PubMed ID: 31422022
[TBL] [Abstract][Full Text] [Related]
16. Progress of targeted and immunotherapy for hepatocellular carcinoma and the application of next-generation sequencing.
Yang F; Deng K; Zheng H; Liu Z; Zheng Y
Ann Hepatol; 2022; 27(2):100677. PubMed ID: 35093601
[TBL] [Abstract][Full Text] [Related]
17. Potentiality of immunotherapy against hepatocellular carcinoma.
Tsuchiya N; Sawada Y; Endo I; Uemura Y; Nakatsura T
World J Gastroenterol; 2015 Sep; 21(36):10314-26. PubMed ID: 26420958
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant versus Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: Clinical and Immunologic Perspectives.
Su YY; Li CC; Lin YJ; Hsu C
Semin Liver Dis; 2021 Aug; 41(3):263-276. PubMed ID: 34130338
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular Carcinoma-The Influence of Immunoanatomy and the Role of Immunotherapy.
Patel K; Lamm R; Altshuler P; Dang H; Shah AP
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32942580
[TBL] [Abstract][Full Text] [Related]
20. [Hepatocellular carcinoma - from immunobiology to immunotherapy].
Flecken T; Schmidt N; Spangenberg HC; Thimme R
Z Gastroenterol; 2012 Jan; 50(1):47-56. PubMed ID: 22222798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
